In a significant advancement for Alzheimer’s treatment, the U.S. Food and Drug Administration (FDA) has approved Eisai and Biogen’s...
Lire la suiteThe brewing sector has been given a major boost with the expansion of a long-standing collaboration between two of...
Lire la suiteOn 24 January 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved garadacimab, marketed under the brand name...
Lire la suiteIn a groundbreaking development for medical science, the INTERCEPT project has launched Europe’s first biomarker trial aimed at preventing...
Lire la suiteTris Pharma, Inc. has announced highly encouraging results from its ALLEVIATE-1 phase 3 clinical trial evaluating cebranopadol as a...
Lire la suiteIn a move that unites two esteemed family-owned brands, Bramble Foods Group, a supplier of branded ambient foods, has...
Lire la suite